Methylprednisolone for Moderate to Severe Traumatic Brain Injury

Clinical trial NCT07180277 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07180277
Sponsor: Zhangjiagang First People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2025-10-01
Primary completion: 2027-10-01
Enrollment: 520

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.